Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial
2024 · Journal of Clinical Oncology · 43 citations
https://doi.org/10.1200/jco.23.01889
Y
Yunfeng Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
707
Citations
13
h-index
13
i10-index
Yunfeng Li is an academic researcher from Beijing Institute of Petrochemical Technology. The author has contributed to research in topics: Atmospheric chemistry and aerosols & Colorectal Cancer Surgical Treatments & Colorectal Cancer Treatments and Studies. The author has an h-index of 13, co-authored 25 publications.
ORCID: 0000-0002-1974-7249Papers by this author
worksNeoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial
2024 · Journal of Clinical Oncology · 43 citations
https://doi.org/10.1200/jco.23.01889
Single-cell sequencing reveals the immune microenvironment landscape related to anti-PD-1 resistance in metastatic colorectal cancer with high microsatellite instability
2023 · BMC Medicine · 40 citations
https://doi.org/10.1186/s12916-023-02866-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat